• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过增强小鼠肠道通透性和内皮细胞Toll样受体4/核因子κB信号通路加重动脉粥样硬化。

aggravates atherosclerosis by enhancing intestinal permeability and endothelial TLR4/NF-κB pathway in mice.

作者信息

Zhang Kun, Qin Xian, Qiu Juhui, Sun Tong, Qu Kai, Din Ahmad Ud, Yan Wenhua, Li Tianhan, Chen Yidan, Gu Wei, Rao Xiancai, Wang Guixue

机构信息

Key Laboratory for Biorheological Science and Technology of Ministry of Education, State and Local Joint Engineering Laboratory for Vascular Implants, College of Bioengineering, Chongqing University, Chongqing 400044, China.

College of Information and Management Sciences, Henan Agricultural University, Zhengzhou, Henan 450046, China.

出版信息

Genes Dis. 2021 Oct 16;10(1):239-253. doi: 10.1016/j.gendis.2021.09.007. eCollection 2023 Jan.

DOI:10.1016/j.gendis.2021.09.007
PMID:37013030
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10066333/
Abstract

It is increasingly aware that gut microbiota is closely associated with atherosclerosis. However, which and how specific gut bacteria regulate the progression of atherosclerosis is still poorly understood. In this study, modified linear discriminant analysis was performed in comparing the gut microbiota structures of atherosclerotic and non-atherosclerotic mice, and () was found to be associated with atherosclerosis. treated mice showed significantly aggravated atherosclerosis. The proatherogenic effect of was attributed to its ability to increase intestinal permeability and subsequent raise in the transit of lipopolysaccharide (LPS) from the intestine to the bloodstream. Excessive LPS in the blood can elicit local and systemic inflammation and activate Toll-like receptor 4 (TLR4)/nuclear factor-κB (NF-κB) signaling of endothelial cells. TAK-242, a specific inhibitor of TLR4, can ameliorate the development of -induced atherosclerosis by blocking the LPS-induced activation of TLR4/NF-κB signaling.

摘要

人们越来越意识到肠道微生物群与动脉粥样硬化密切相关。然而,具体哪些肠道细菌以及如何调节动脉粥样硬化的进展仍知之甚少。在本研究中,通过改良线性判别分析比较动脉粥样硬化小鼠和非动脉粥样硬化小鼠的肠道微生物群结构,发现(此处原文缺失相关内容)与动脉粥样硬化有关。用(此处原文缺失相关内容)处理的小鼠动脉粥样硬化明显加重。(此处原文缺失相关内容)的促动脉粥样硬化作用归因于其增加肠道通透性以及随后脂多糖(LPS)从肠道向血液转运增加的能力。血液中过量的LPS可引发局部和全身炎症,并激活内皮细胞的Toll样受体4(TLR4)/核因子-κB(NF-κB)信号通路。TAK-242是TLR4的特异性抑制剂,可通过阻断LPS诱导的TLR4/NF-κB信号通路激活来改善(此处原文缺失相关内容)诱导的动脉粥样硬化发展。

相似文献

1
aggravates atherosclerosis by enhancing intestinal permeability and endothelial TLR4/NF-κB pathway in mice.通过增强小鼠肠道通透性和内皮细胞Toll样受体4/核因子κB信号通路加重动脉粥样硬化。
Genes Dis. 2021 Oct 16;10(1):239-253. doi: 10.1016/j.gendis.2021.09.007. eCollection 2023 Jan.
2
TLR4/NF-κB signaling contributes to chronic unpredictable mild stress-induced atherosclerosis in ApoE-/- mice.Toll样受体4/核因子κB信号通路促进载脂蛋白E基因敲除小鼠慢性不可预测轻度应激诱导的动脉粥样硬化。
PLoS One. 2015 Apr 10;10(4):e0123685. doi: 10.1371/journal.pone.0123685. eCollection 2015.
3
Melatonin mitigates aflatoxin B1-induced liver injury via modulation of gut microbiota/intestinal FXR/liver TLR4 signaling axis in mice.褪黑素通过调节肠道微生物群/肠道 FXR/肝脏 TLR4 信号轴减轻黄曲霉毒素 B1 诱导的小鼠肝损伤。
J Pineal Res. 2022 Sep;73(2):e12812. doi: 10.1111/jpi.12812. Epub 2022 Jun 12.
4
Pinocembrin alleviates ulcerative colitis in mice via regulating gut microbiota, suppressing TLR4/MD2/NF-κB pathway and promoting intestinal barrier.白杨素通过调节肠道微生物群、抑制 TLR4/MD2/NF-κB 途径和促进肠道屏障来减轻小鼠溃疡性结肠炎。
Biosci Rep. 2020 Jul 31;40(7). doi: 10.1042/BSR20200986.
5
Caprylic acid suppresses inflammation via TLR4/NF-κB signaling and improves atherosclerosis in ApoE-deficient mice.辛酸通过TLR4/NF-κB信号通路抑制炎症并改善载脂蛋白E缺陷小鼠的动脉粥样硬化。
Nutr Metab (Lond). 2019 Jun 6;16:40. doi: 10.1186/s12986-019-0359-2. eCollection 2019.
6
Qingrequzhuo capsule alleviated methionine and choline deficient diet-induced nonalcoholic steatohepatitis in mice through regulating gut microbiota, enhancing gut tight junction and inhibiting the activation of TLR4/NF-κB signaling pathway.清胰浊脂胶囊通过调节肠道微生物群、增强肠道紧密连接和抑制 TLR4/NF-κB 信号通路的激活,缓解蛋氨酸和胆碱缺乏饮食诱导的非酒精性脂肪性肝炎小鼠模型的肝损伤。
Front Endocrinol (Lausanne). 2023 Jan 19;13:1106875. doi: 10.3389/fendo.2022.1106875. eCollection 2022.
7
MiR-590 Inhibits Endothelial Cell Apoptosis by Inactivating the TLR4/NF-κB Pathway in Atherosclerosis.微小RNA-590通过使动脉粥样硬化中的Toll样受体4/核因子κB信号通路失活来抑制内皮细胞凋亡。
Yonsei Med J. 2019 Mar;60(3):298-307. doi: 10.3349/ymj.2019.60.3.298.
8
New role of PCSK9 in atherosclerotic inflammation promotion involving the TLR4/NF-κB pathway.前蛋白转化酶枯草溶菌素9(PCSK9)在涉及Toll样受体4(TLR4)/核因子κB(NF-κB)途径的动脉粥样硬化炎症促进中的新作用。
Atherosclerosis. 2017 Jul;262:113-122. doi: 10.1016/j.atherosclerosis.2017.04.023. Epub 2017 Apr 29.
9
Contribution of TLR4 signaling in intermittent hypoxia-mediated atherosclerosis progression.TLR4 信号通路在间歇性低氧介导的动脉粥样硬化进展中的作用。
J Transl Med. 2018 Apr 19;16(1):106. doi: 10.1186/s12967-018-1479-6.
10
Role of toll-like receptor 4 on lupus lung injury and atherosclerosis in LPS-challenge ApoE⁻/⁻ mice.Toll样受体4在脂多糖刺激的载脂蛋白E基因敲除小鼠狼疮性肺损伤和动脉粥样硬化中的作用
Clin Dev Immunol. 2013;2013:476856. doi: 10.1155/2013/476856. Epub 2013 Sep 15.

引用本文的文献

1
Elucidating the gut microbiota-driven crosstalk: mechanistic interplay of lobetyolin in coordinating cholesterol homeostasis and anti-inflammatory pathways in hyperlipidemic mice models.阐明肠道微生物群驱动的串扰:在高脂血症小鼠模型中,洛贝林在协调胆固醇稳态和抗炎途径中的机制相互作用。
Front Microbiol. 2025 Aug 19;16:1625211. doi: 10.3389/fmicb.2025.1625211. eCollection 2025.
2
Physical Activity and Metabolic Disorders-What Does Gut Microbiota Have to Do with It?体力活动与代谢紊乱——肠道微生物群与此有何关联?
Curr Issues Mol Biol. 2025 Aug 7;47(8):630. doi: 10.3390/cimb47080630.
3
Gut microbiota regulate atherosclerosis via the gut-vascular axis: a scoping review of mechanisms and therapeutic interventions.肠道微生物群通过肠-血管轴调节动脉粥样硬化:机制与治疗干预的范围综述
Front Microbiol. 2025 Aug 8;16:1606309. doi: 10.3389/fmicb.2025.1606309. eCollection 2025.
4
Hematopoietic effects of Fufang E'jiao Jiang revealed by microbiome, metabolome and transcriptome analyses: a multi-omics strategy.微生物组、代谢组和转录组分析揭示的复方阿胶浆造血作用:一种多组学策略
Front Immunol. 2025 Jun 12;16:1561477. doi: 10.3389/fimmu.2025.1561477. eCollection 2025.
5
exacerbates sepsis by inducing inflammation and oxidative stress in multiple organs.通过在多个器官中引发炎症和氧化应激来加重败血症。
Front Microbiol. 2025 Apr 30;16:1574998. doi: 10.3389/fmicb.2025.1574998. eCollection 2025.
6
Systemic lupus erythematosus and atherosclerosis: immune pathways and the uncharted territory of gut microbiota and metabolism.系统性红斑狼疮与动脉粥样硬化:免疫途径以及肠道微生物群和代谢的未知领域
Front Immunol. 2025 Apr 28;16:1492726. doi: 10.3389/fimmu.2025.1492726. eCollection 2025.
7
Effects of Algal-Derived -Glucan on the Growth Performance, Intestinal Health, and Resistance of Ricefield Eel ().藻类衍生的β-葡聚糖对黄鳝生长性能、肠道健康及抵抗力的影响
Aquac Nutr. 2025 Jan 21;2025:8172810. doi: 10.1155/anu/8172810. eCollection 2025.
8
Explore Alteration of Lung and Gut Microbiota in a Murine Model of OVA-Induced Asthma Treated by CpG Oligodeoxynucleotides.探索经CpG寡脱氧核苷酸治疗的卵清蛋白诱导哮喘小鼠模型中肺和肠道微生物群的变化。
J Inflamm Res. 2025 Jan 11;18:445-461. doi: 10.2147/JIR.S487916. eCollection 2025.
9
The Role of on Improving Gut and Metabolic Health Modulation: A Meta-Analysis of Preclinical Mouse Model Studies.[具体物质名称]对改善肠道和代谢健康调节的作用:临床前小鼠模型研究的荟萃分析
Microorganisms. 2024 Aug 9;12(8):1627. doi: 10.3390/microorganisms12081627.
10
Recent progresses in gut microbiome mediates obstructive sleep apnea-induced cardiovascular diseases.肠道微生物群的最新进展介导阻塞性睡眠呼吸暂停引起的心血管疾病。
FASEB Bioadv. 2024 Mar 6;6(4):118-130. doi: 10.1096/fba.2023-00153. eCollection 2024 Apr.

本文引用的文献

1
A New Combination of Substrates: Biogas Production and Diversity of the Methanogenic Microorganisms.新型底物组合:沼气生产与产甲烷微生物的多样性
Open Life Sci. 2018 Apr 23;13:119-128. doi: 10.1515/biol-2018-0017. eCollection 2018 Jan.
2
Downregulation of G3BP2 reduces atherosclerotic lesions in ApoE mice.下调 G3BP2 减少 ApoE 小鼠的动脉粥样硬化病变。
Atherosclerosis. 2020 Oct;310:64-74. doi: 10.1016/j.atherosclerosis.2020.08.003. Epub 2020 Aug 27.
3
Anti-atherosclerotic effects of Lactobacillus plantarum ATCC 14917 in ApoE mice through modulation of proinflammatory cytokines and oxidative stress.植物乳杆菌 ATCC 14917 通过调节促炎细胞因子和氧化应激对载脂蛋白 E 基因敲除小鼠的抗动脉粥样硬化作用。
Appl Microbiol Biotechnol. 2020 Jul;104(14):6337-6350. doi: 10.1007/s00253-020-10693-x. Epub 2020 May 29.
4
Increased Colonic Epithelial Permeability and Mucosal Eosinophilia in Ulcerative Colitis in Remission Compared With Irritable Bowel Syndrome and Health.与肠易激综合征和健康对照相比,缓解期溃疡性结肠炎患者结肠上皮通透性增加和黏膜嗜酸性粒细胞增多。
Inflamm Bowel Dis. 2020 Jun 18;26(7):974-984. doi: 10.1093/ibd/izz328.
5
Therapeutic targeting of circ-CUX1/EWSR1/MAZ axis inhibits glycolysis and neuroblastoma progression.靶向环状 RNA-CUX1/EWSR1/MAZ 轴抑制糖酵解并抑制神经母细胞瘤进展。
EMBO Mol Med. 2019 Dec;11(12):e10835. doi: 10.15252/emmm.201910835. Epub 2019 Nov 11.
6
Amelioration of TMAO through probiotics and its potential role in atherosclerosis.通过益生菌改善 TMAO 及其在动脉粥样硬化中的潜在作用。
Appl Microbiol Biotechnol. 2019 Dec;103(23-24):9217-9228. doi: 10.1007/s00253-019-10142-4. Epub 2019 Oct 26.
7
Rescue fecal microbiota transplantation for antibiotic-associated diarrhea in critically ill patients.采用粪菌移植抢救危重症患者抗生素相关性腹泻。
Crit Care. 2019 Oct 21;23(1):324. doi: 10.1186/s13054-019-2604-5.
8
Biomimetic Nanotherapies: Red Blood Cell Based Core-Shell Structured Nanocomplexes for Atherosclerosis Management.仿生纳米疗法:用于动脉粥样硬化治疗的基于红细胞的核壳结构纳米复合物
Adv Sci (Weinh). 2019 Apr 24;6(12):1900172. doi: 10.1002/advs.201900172. eCollection 2019 Jun 19.
9
Hydrogen Sulfide as a Toxic Product in the Small-Large Intestine Axis and its Role in IBD Development.硫化氢作为小肠-大肠轴中的一种毒性产物及其在炎症性肠病发展中的作用。
J Clin Med. 2019 Jul 19;8(7):1054. doi: 10.3390/jcm8071054.
10
Monocyte chemoattractant protein-1 (MCP-1) and fibroblast growth factor-21 (FGF-21) as biomarkers of subclinical atherosclerosis in women.单核细胞趋化蛋白-1(MCP-1)和成纤维细胞生长因子-21(FGF-21)作为女性亚临床动脉粥样硬化的生物标志物。
Exp Gerontol. 2019 Sep;124:110624. doi: 10.1016/j.exger.2019.05.013. Epub 2019 May 29.